Immunization against 5alpha-androstane-3alpha,17beta-diol affects ovarian folliculogenesis in Merino ewes.
The 5alpha-reduced androgens have been implicated as antagonists of follicular development. In this experiment, we examined the effect of active immunization against 5alpha-reduced androgen on follicular development in ewes. During the breeding season, cyclic Merino ewes were either actively immunized three times against 5alpha-androstane-3alpha,17beta-diol (3alpha-diol) or served as controls. Six to nine weeks after the last immunization, they were treated with PGF(2alpha) analog (PG, 125mg cloprostenol i.m.) and luteolysis was induced. Fourteen days after the PG treatment, the ewes were either killed (mid-luteal phase) or treated a second time with PG and killed 24h later (early follicular phase). At slaughter, blood samples were collected and ovaries recovered. All CL and follicles larger than 2mm were dissected and their size and appearance were recorded. Follicular fluid was collected and concentrations of estradiol-17beta (E(2)), progesterone (P), androstenedione (A(4)), testosterone (T), dihydrotestosterone (DHT), 5alpha-androstane-3alpha-ol,17beta-one (androsterone: 3alpha-ol) and 3alpha-diol were determined by RIA. Immunization induced antibodies primarily to DHT and its 5alpha-reduced substrates 3alpha-diol and 3alpha-ol but not to E(2), P, A(4) or T. Immunization increased ovulation rate, size of ovulatory follicles and weight of CL. Immunization appeared to increase ovulation rate by decreasing the incidence of atresia in large preovulatory follicles. Regardless of their physiological status follicles contained only low levels of DHT; 3alpha-ol and 3alpha-diol were not detected in most follicles. Immunization did not appear to affect levels of DHT or other steroids in the follicular fluid. In conclusion, the induction of antibodies to 5alpha-reduced androgens increases ovulation rate by enhancing follicular viability during the preovulatory period in ewes. However, this effect is not brought about by the direct immune-neutralization of DHT or its 5alpha-reduced substrates 3alpha-ol and 3alpha-diol at the ovarian level.
Tetsuka
Masa
M
Department of Wool and Animal Science, The University of New South Wales, P.O. Box 1, Kensington, Australia. mtetsuka@obihiro.ac.jp
Nancarrow
Colin D
CD
D015113:Androstane-3,17-diol / Q000032:analysis / Q000276:immunology*; D000735:Androstenedione / Q000032:analysis; D000738:Androsterone / Q000032:analysis / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000097:blood; D001947:Breeding; D003008:Cloprostenol / Q000008:administration & dosage; D003338:Corpus Luteum / Q000502:physiology; D013196:Dihydrotestosterone / Q000032:analysis / Q000276:immunology; D004958:Estradiol / Q000032:analysis; D005260:Female; D015571:Follicular Fluid / Q000737:chemistry; D007114:Immunization / Q000662:veterinary*; D006080:Ovarian Follicle / Q000502:physiology*; D010060:Ovulation; D011374:Progesterone / Q000032:analysis; D012621:Seasons; D012756:Sheep / Q000502:physiology*; D013739:Testosterone / Q000032:analysis
D000906:Antibodies; D013196:Dihydrotestosterone; D015113:Androstane-3,17-diol; D013739:Testosterone; D000735:Androstenedione; D003008:Cloprostenol; D011374:Progesterone; D004958:Estradiol; D000738:Androsterone